Valuation: Incyte Corporation

Market Cap 2.34TCr 12TCr 2.08TCr 1.94TCr 1.77TCr 3.33TCr 2,24700Cr 3.36TCr 23TCr 9.09TCr 1,14900Cr 8.77TCr 8.58TCr 3,68600Cr P/E 2026 *
54x
P/E 2027 * 15.9x
Enterprise Value 1.91TCr 10TCr 1.7TCr 1.58TCr 1.44TCr 2.72TCr 1,83600Cr 2.75TCr 19TCr 7.43TCr 94TCr 7.17TCr 7.01TCr 3,01200Cr EV / Sales 2026 *
3.21x
EV / Sales 2027 * 2.78x
Free-Float
98.15%
Yield 2026 *
-
Yield 2027 * -
1 day-3.99%
1 week-8.34%
Current month-8.34%
1 month-6.90%
3 months+0.53%
6 months+23.49%
Current year+7.73%
1 week 298.53
Extreme 298.53
310.93
1 month 298.53
Extreme 298.53
326.7
Current year 232.56
Extreme 232.56
328.68
1 year 232.56
Extreme 232.56
328.68
3 years 135.9
Extreme 135.9
328.68
5 years 135.9
Extreme 135.9
328.68
10 years 135.9
Extreme 135.9
328.68
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Change 5-day change 1-year change 3-year change Capi.($)
-3.99%-8.34% - - 2.34TCr
-0.61%-3.43%+39.40%+112.31% 1,01900Cr
-1.02%-5.60%+37.67%+65.02% 62TCr
+1.11%-0.58%+11.10%+77.28% 46TCr
+0.34%-3.01%+61.21%+40.71% 36TCr
-0.95%-4.05%+21.60%+39.37% 33TCr
-1.46%-2.89%+11.84%+24.60% 27TCr
-1.35%-5.43%-4.69%+8.40% 24TCr
-1.04%-2.79%+35.52%+51.34% 22TCr
-1.87%-4.10%+30.92%+95.33% 18TCr
Average -0.61%-3.39%+27.17%+57.15% 41.08TCr
Weighted average by Cap. +0.39%-3.33%+30.52%+68.96%

Financials

2026 *2027 *
Net sales 593.96Cr 3.11TCr 527.73Cr 492.55Cr 448.95Cr 846.71Cr 57TCr 854.59Cr 5.96TCr 2.31TCr 29TCr 2.23TCr 2.18TCr 94TCr 625.83Cr 3.28TCr 556.05Cr 518.98Cr 473.03Cr 892.14Cr 60TCr 900.44Cr 6.28TCr 2.43TCr 31TCr 2.35TCr 2.3TCr 99TCr
Net income 44Cr 232.86Cr 40Cr 37Cr 34Cr 63Cr 4.28TCr 64Cr 446.45Cr 173Cr 2.19TCr 167.02Cr 163.4Cr 7.02TCr 150.39Cr 787.2Cr 133.62Cr 124.71Cr 113.67Cr 214.38Cr 14TCr 216.38Cr 1.51TCr 584.83Cr 7.39TCr 564.63Cr 552.37Cr 24TCr
Net Debt -427.56Cr -2.24TCr -379.88Cr -354.56Cr -323.17Cr -609.49Cr -41TCr -615.17Cr -4.29TCr -1.66TCr -21TCr -1.61TCr -1.57TCr -67TCr -596.07Cr -3.12TCr -529.61Cr -494.3Cr -450.54Cr -849.71Cr -57TCr -857.62Cr -5.98TCr -2.32TCr -29TCr -2.24TCr -2.19TCr -94TCr
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
02/26/02 R$298.53 -3.99% 900
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
115.30USD
Average target price
128.42USD
Spread / Average Target
+11.38%

Quarterly revenue - Rate of surprise